Igentify Revenue and Competitors

Claim your profile

Tel Aviv, Israel

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Igentify's estimated annual revenue is currently $23.8M per year.(i)
  • Igentify's estimated revenue per employee is $270,000

Employee Data

  • Igentify has 88 Employees.(i)
  • Igentify grew their employee count by 22% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$26.5M9814%N/AN/A
#2
$6.7M31N/AN/AN/A
#3
$32.1M11910%N/AN/A
#4
$8.4M39129%N/AN/A
#5
$3.1M19111%N/AN/A
#6
$23.8M8822%N/AN/A
#7
$8M3723%N/AN/A

Igentify® is a digital health company. It has developed the world's first Digital Genetic Counselor – a digital platform for genetic tests providers. The platform is capable of providing a fully scalable end-to-end genetic counseling solution in both clinical as well as non-clinical (direct-to-consumer) genetic testing set up. The platform is built for various genotyping technologies like microarray and next-generation sequencing (NGS). It can be customized to a broad spectrum of genetic and genomic tests offered by the test providers. The platform's unmatched user engaging capabilities enable the test providers to give the best user experience to their consumers from enrollment & personalized consent for the genetic test, to the automated delivery of machine-generated personalized genetic counseling. Igentify's advanced and unique technology will bring precision medicine to fruition. Founded in Oct. 2016, Igentify's team of globally renowned geneticists, highly experienced software developers, creative animators, and UX/UI designers, is redefining the protocols of traditional medicine. In Jan. 2019, Deloitte has selected Igentify as one of the Israeli startups at the forefront of the Digital R&D Revolution.

keywords:N/A

N/A

Total Funding

88

Number of Employees

$23.8M

Revenue (est)

22%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15.7M112N/AN/A
#2
$16.2M11653%$45.1M
#3
$34.8M1291%N/A
#4
N/A13930%N/A
#5
$27.1M17650%N/A